Our in vitro analyses of human breast cancer cells reveal that ERα positively regulates MDM4 and MDM2 expression via p53-independent mechanisms, while MDM4 and MDM2 negatively regulate ERα expression. This evidence concerns the gene TP53 and breast carcinoma.